Prophylaxis of Venous Thromboembolism in Advanced Lung Cancer
Status:
Unknown status
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
To compare the efficacy and safety of prophylaxis of venous thromboembolism by Nadroparin
during hospitalization to long-term usage in patients with advanced lung cancer treated by
chemotherapy and/or radiotherapy.